Picture of Solid Biosciences logo

SLDB Solid Biosciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Solid Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments83.5155208214124
Net Total Accounts Receivable
Net Total Receivables0.110
Prepaid Expenses
Total Current Assets86.3159223220130
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment16.611.77.638.633.2
Other Long Term Assets
Total Assets103171232260165
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities18.324.523.622.514.5
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities23.439.124.248.638.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity80132208212126
Total Liabilities & Shareholders' Equity103171232260165
Total Common Shares Outstanding